Beximco buys stake in Bangladesh-based Nuvista Pharma for up to £18.3m

AIM-listed Beximco Pharmaceuticals has bought a majority stake in Bangladesh-based Nuvista Pharma, which specialises in hormones and steroid drugs, for up to £18.2m. Beximco has entered into share purchase agreements with six shareholders with an aggregate shareholding of 85.2% in Nuvista. The final consideration will paid in cash on completion of the acquisition, which is expected to occur on or before 28 February. Nuvista was a subsidiary of Netherlands-based Organon International. It was ...

Den vollständigen Artikel lesen ...